Drug Patents owned by Genus Lifesciences

1. List of Goprelto drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10933060 GENUS LIFESCIENCES Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10973811 GENUS LIFESCIENCES Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10987347 GENUS LIFESCIENCES Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10894012 GENUS LIFESCIENCES Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10857095 GENUS LIFESCIENCES Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10231961 GENUS LIFESCIENCES Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US11040032 GENUS LIFESCIENCES Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10016407 GENUS LIFESCIENCES Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US9867815 GENUS LIFESCIENCES Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10413505 GENUS LIFESCIENCES Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10420760 GENUS LIFESCIENCES Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

US10149843 GENUS LIFESCIENCES Pharmaceutical compositions and methods of using the same
Feb, 2037

(13 years from now)

Do you want to check out GOPRELTO patents from before 2022?
Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Dec 14, 2022

Drugs and Companies using COCAINE HYDROCHLORIDE ingredient

NCE-1 date: 2021-12-14

Market Authorisation Date: 14 December, 2017

Treatment: Method for the induction of local anesthesia of the mucous membranes; Method of administering a local anesthetic to the mucous membranes in patients with renal impairment; Method of administering a lo...

Dosage: SOLUTION;NASAL

More Information on Dosage

GOPRELTO family patents

14

United States

2. List of Levolet drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10231931 GENUS LIFESCIENCES Thyroid hormone oral dosage forms and methods of using the same
Mar, 2038

(14 years from now)

US10406108 GENUS LIFESCIENCES Thyroid hormone oral dosage forms and methods of using the same
Mar, 2038

(14 years from now)

Do you want to check out LEVOLET patents from before 2022?

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 06 June, 2003

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

3. List of Yosprala drug patents

YOSPRALA's oppositions filed in EPO
YOSPRALA Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9364439 GENUS LIFESCIENCES Pharmaceutical compositions for the coordinated delivery of NSAIDs
May, 2022

(1 year, 3 days ago)

US6926907 GENUS LIFESCIENCES Pharmaceutical compositions for the coordinated delivery of NSAIDs
Feb, 2023

(3 months ago)

US8206741 GENUS LIFESCIENCES Pharmaceutical compositions for the coordinated delivery of NSAIDs
Feb, 2023

(3 months ago)

US9987231 GENUS LIFESCIENCES Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
Jan, 2033

(9 years from now)

US9539214 GENUS LIFESCIENCES Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
Mar, 2033

(9 years from now)

Do you want to check out YOSPRALA patents from before 2022?

Drugs and Companies using ASPIRIN; OMEPRAZOLE ingredient

Market Authorisation Date: 14 September, 2016

Treatment: Treatment or secondary prevention of cardiovascular disease, cardiovascular events, or cerebrovascular events and risk-reduction of aspirin-associated gastric ulcers; For secondary prevention of cardi...

Dosage: TABLET, DELAYED RELEASE;ORAL

How can I launch a generic of YOSPRALA before it's patent expiration?
More Information on Dosage

YOSPRALA family patents

27

United States

5

European Union

4

Australia

EA

3

EA

3

Canada

3

Mexico

2

Japan

2

Norway

2

Brazil

2

China

1

Luxembourg

1

Israel

1

Korea, Republic of

1

Denmark

1

Spain

1

Tunisia

1

Austria

1

Cyprus

1

Portugal

1

Ukraine

1

Morocco

1

United Kingdom

1

Germany

1

South Africa

1

Belgium

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic